Skip to main content

Advances in clinical trials in PAH: hope for new therapies
Monday, Oct. 16th, at 1PM PST / 4 PM EST

Join us for an informative session where Dr. David Langleben will discuss advances in clinical trials in PAH. Dr. Langleben will be discussing clinical trial results on some of the current medications being tested including apabetalone, seralutinib, imatinib, and sotatercept. He will also review the importance of cell proliferation in the development of PAH and discuss the meaning of different phases of drug development.

Dr. David Langleben is a Professor of Medicine at McGill University, Senior Staff Cardiologist at the Jewish General Hospital and Director of the Centre for Pulmonary Vascular Disease.

Click here to register